Markus Cappel's Email & Phone

Markus J. Cappel, Chief Business Officer. Dr. Cappel has extensive expertise in forming strategic alliances with major pharmaceutical and biotechnology companies. Prior to joining ChemoCentryx in 2001, Dr. Cappel served as Vice President of Business Development at Alkermes, Inc., where he was responsible for the company's AIR pulmonary drug delivery platform. While there, he contributed to forging two major alliances with Eli Lilly, a multi-product deal with GlaxoSmithKline and an exclusive development partnership with MedImmune. Previously, he was Director of Business Development with Millennium Pharmaceuticals, where he was responsible for negotiating drug discovery partnerships with large pharmaceutical companies. Dr. Cappel was also Director of Business Development with Cygnus Corporation, responsible for partnering activities in Europe and Japan. Dr. Cappel received his B.S. in Pharmacy and a Ph.D. in Pharmaceutics from J.W. Goethe University, Frankfurt, Germany, as well as an MBA from Harvard Business School.